Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for early postoperative cognitive dysfunction in anxious elderly patients undergoing gastrointestinal tumor surgery
ChiCTR2200064031Phase 4Recruiting
- Sponsor
- Second Affiliated Hospital of Guangzhou Medical University
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esketamine in perioperative neurocognitive disorder (2 arms), sponsored by Second Affiliated Hospital of Guangzhou Medical University. Primary endpoint: Cognitive function. Started Jun 2022; status: recruiting.
02
Drugs
esketamine
03
Conditions
perioperative neurocognitive disorder
Beyond the preview
Go deeper on ChiCTR2200064031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200064031.